Pavel Elkin

Senior Scientist Ii @AbbVie

Design of novel drug-like compounds utilizing crystallographic information and molecular modeling tools (Maestro, Spark, Torch, etc.); design and prioritization of novel compounds based on the Structure-Activity Relationship (SAR) studies; metabolism-guided drug design; synthesis and optimization of Beyond Rule of Five (BRO 5) compounds Synthesis of novel drug-like candidates for the treatment of oncology diseases; development and execution of the complex multistep scalable synthesis of potentially bioactive molecules Preparation of patent applications regarding novel active pharmaceutical ingredients